Hemophagocytic syndrome after living-donor liver transplantation for fulminant liver failure: a case report.

Nobuhiko Taniai, Koho Akimaru, Youichi Kawano, Yoshiaki Mizuguchi, Tetsuya Shimizu, Tsubasa Takahashi, Yasuhiro Mamada, Hiroshi Yoshida, Takashi TajiriPubMed 2005

Abstract

Hemophagocytic syndrome (HPS) is a hypercytokinemia caused by activated T lymphocytes and macrophages in immunologically compromised patients. We report a 37-year-old female who was diagnosed with HPS after undergoing living-donor liver transplantation (LDLT) for fulminant liver failure of unknown etiology. After liver transplantation, recipients with pancytopenia should be tested for serum ferritin. When the serum ferritin is abnormal, the bone marrow should be biopsied to screen for HPS as soon as possible. If the condition is caught early and promptly treated, the outcome of this devastating condition might be improved. In addition, HPS should be ruled out in LDLT candidates with acute liver failure before their operations.
BibTeX
@inproceedings{taniai2005hemophagocytic,
  author = {Nobuhiko Taniai and Koho Akimaru and Youichi Kawano and Yoshiaki Mizuguchi and Tetsuya Shimizu and Tsubasa Takahashi and Yasuhiro Mamada and Hiroshi Yoshida and Takashi Tajiri},
  title = {{Hemophagocytic syndrome after living-donor liver transplantation for fulminant liver failure: a case report.}},
  booktitle = {PubMed},
  year = {2005},
}

Loading related content...

Figure